As on Wednesday, Boston Scientific Corp. (NYSE: BSX) started slowly as it slid -1.06% to $77.76, before settling in for the price of $78.59 at the close. Taking a more long-term approach, BSX posted a 52-week range of $48.35-$79.43.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare sector firm’s twelve-monthly sales growth has been 8.10% for the last half of the decade. Meanwhile, its Annual Earning per share during the time was -2.05%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 15.75%. This publicly-traded company’s shares outstanding now amounts to $1.47 billion, simultaneously with a float of $1.46 billion. The organization now has a market capitalization sitting at $114.32 billion. At the time of writing, stock’s 50-day Moving Average stood at $76.34, while the 200-day Moving Average is $65.00.
Boston Scientific Corp. (BSX) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Medical Devices industry. Boston Scientific Corp.’s current insider ownership accounts for 0.45%, in contrast to 93.01% institutional ownership. According to the most recent insider trade that took place on Jul 01 ’24, this organization’s EVP, Human Resources sold 6,983 shares at the rate of 77.30, making the entire transaction reach 539,786 in total value, affecting insider ownership by 42,908. Preceding that transaction, on Jun 03 ’24, Company’s EVP, Human Resources sold 6,983 for 75.33, making the whole transaction’s value amount to 526,029. This particular insider is now the holder of 45,628 in total.
Boston Scientific Corp. (BSX) Earnings and Revenue Records
If we go through the results of last quarter, which was made public on 6/30/2024, the company posted 0.5 earnings per share (EPS) for the quarter, besting the agreed prediction (set at 0.48) by 0.02. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.63 per share during the current fiscal year.
Boston Scientific Corp.’s EPS increase for this current 12-month fiscal period is 15.75% and is forecasted to reach 2.69 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 12.40% through the next 5 years, which can be compared against the -2.05% growth it accomplished over the previous five years trading on the market.
Boston Scientific Corp. (NYSE: BSX) Trading Performance Indicators
Let’s observe the current performance indicators for Boston Scientific Corp. (BSX). It’s Quick Ratio in the last reported quarter now stands at 1.14. The Stock has managed to achieve an average true range (ATR) of 1.38. Alongside those numbers, its PE Ratio stands at $64.97, and its Beta score is 0.79. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 7.77. Similarly, its price to free cash flow for trailing twelve months is now 67.33.
In the same vein, BSX’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 1.20, a figure that is expected to reach 0.60 in the next quarter, and analysts are predicting that it will be 2.69 at the market close of one year from today.
Technical Analysis of Boston Scientific Corp. (BSX)
Through scrutinizing the latest numbers posted by the [Boston Scientific Corp., BSX], it can be observed that its last 5-days Average volume of 9.25 million was better the volume of 6.25 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 79.24% While, its Average True Range was 1.54.
Raw Stochastic average of Boston Scientific Corp. (BSX) in the period of the previous 100 days is set at 87.99%, which indicates a major rise in contrast to 68.35% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 17.98% that was higher than 16.82% volatility it exhibited in the past 100-days period.
